Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity (Q43145481)

14 November 2017

Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity (English)

1 reference

14 November 2017

1 reference

0 references

1 reference

S Yamada

1

1 reference

14 November 2017

K Richardson

2

1 reference

14 November 2017

M Tang

3

1 reference

14 November 2017

J Halaschek-Wiener

4

1 reference

14 November 2017

V J Cook

5

1 reference

14 November 2017

J M Fitzgerald

6

1 reference

14 November 2017

K Elwood

7

1 reference

14 November 2017

F Marra

8

1 reference

14 November 2017

A Brooks-Wilson

9

1 reference

14 November 2017

2 March 2010

1 reference

The Pharmacogenomics Journal

14 November 2017

1 reference

14 November 2017

10

1 reference

14 November 2017

6

1 reference

14 November 2017

524-536

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2010.5

14 November 2017

0 references

cites work

Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Liver injury during antituberculosis treatment: an 11-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Clinical study of cryoglobulinaemia in Chinese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Structure, function and regulation of carboxylesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Conserved Noncoding Sequences among Cultivated Cereal Genomes Identify Candidate Regulatory Sequence Elements and Patterns of Promoter Evolution[W]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Consed: a graphical tool for sequence finishing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Towards a structural basis of human non-synonymous single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Prediction of deleterious human alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Functional characterization of three naturally occurring single nucleotide polymorphisms in the CES2 gene encoding carboxylesterase 2 (HCE-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Pharmacogenomics of anti-TB drugs-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Pseudogenes: Are They “Junk” or Functional DNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

The importance and identification of regulatory polymorphisms and their mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.5

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.5

1 reference

release_sqgz3gowxjbcbd7nvin4dbjymu

14 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sqgz3gowxjbcbd7nvin4dbjymu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference